glp 1 for insulin resistance One in 10 people may have to GLP-1 diabetes drugs Frontiers | Tirzepatide against obesity

Neurologically, preclinical studies have documented BPC-157 modulation of dopaminergic and serotonergic systems, enhancement of growth hormone receptor expression, and neuroprotective effects against excitotoxicity

Immune system reactions Repeated injections of peptides can sometimes trigger immune responses

What this implies: if the vial remains sealed, in a cool, dry, dark place (ideally under refrigeration or freezing, with minimal humidity), you can reasonably expect 2-3 years of viability in the lyophilized state

Because it promotes new blood vessel growth, there is a theoretical concern in patients with active malignancy the same concern applies to any pro-angiogenic compound